Exact Sciences (EXAS) Net Income towards Common Stockholders (2016 - 2025)
Historic Net Income towards Common Stockholders for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to -$19.6 million.
- Exact Sciences' Net Income towards Common Stockholders rose 4875.51% to -$19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$986.6 million, marking a year-over-year decrease of 36085.67%. This contributed to the annual value of -$1.0 billion for FY2024, which is 40397.36% down from last year.
- According to the latest figures from Q3 2025, Exact Sciences' Net Income towards Common Stockholders is -$19.6 million, which was up 4875.51% from -$1.2 million recorded in Q2 2025.
- Over the past 5 years, Exact Sciences' Net Income towards Common Stockholders peaked at $794000.0 during Q3 2023, and registered a low of -$864.6 million during Q4 2024.
- Its 5-year average for Net Income towards Common Stockholders is -$135.5 million, with a median of -$101.2 million in 2025.
- In the last 5 years, Exact Sciences' Net Income towards Common Stockholders soared by 10053.37% in 2023 and then crashed by 491561.71% in 2024.
- Over the past 5 years, Exact Sciences' Net Income towards Common Stockholders (Quarter) stood at -$220.6 million in 2021, then skyrocketed by 42.09% to -$127.8 million in 2022, then soared by 61.05% to -$49.8 million in 2023, then plummeted by 1637.3% to -$864.6 million in 2024, then skyrocketed by 97.73% to -$19.6 million in 2025.
- Its last three reported values are -$19.6 million in Q3 2025, -$1.2 million for Q2 2025, and -$101.2 million during Q1 2025.